Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by the abnormal and chronic lung inflammation. We hypothesized that lung fibroblasts could contribute to the local inflammation and investigated whether low dose theophylline had a beneficial effect on fibroblasts inflammation. Subjects undergoing lobectomy for bronchial carcinoma were enrolled and divided into COPD and control groups according to spirometry. Primary human lung fibroblasts were cultured from peripheral lung tissue distant to tumor tissue. There was a significant increase in both the mRNA expressions and protein levels for IL-6 and IL-8 in fibroblasts in COPD group, and the values were negatively correlated with lung function (P < 0.05). For COPD fibroblasts, the protein levels of IL-6 and IL-8 decreased from 993.0 ± 738.9 pg/mL to 650.1 ± 421.9 pg/mL (P = 0.014) and from 703.1 ± 278.0 pg/mL to 492.0 ± 214.9 pg/mL (P = 0.001), respectively, with 5 μg/mL theophylline treatment. In addition, theophylline at the dose of 5 μg/mL reduced the increased production of IL-6 and IL-8 induced by 1 μg/mL LPS in primary human lung fibroblasts. Our data suggest that lung fibroblasts participate in the chronic inflammation in COPD by releasing IL-6 and IL-8, and low dose theophylline can alleviate the proinflammatory mediators' production by fibroblasts.

Highlights

  • Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide and results in an economic and social burden that is both substantial and increasing [1]

  • Chronic inflammation of the small airway and surrounding lung parenchyma involving a variety of cells and inflammatory mediators is presumably of major importance in the development and progression of COPD [3, 4]

  • We found that compared with the control group with normal lung function, primary lung fibroblasts from subjects with COPD produced higher levels of IL-6 and IL-8 which were reduced by theophylline in vitro

Read more

Summary

Introduction

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide and results in an economic and social burden that is both substantial and increasing [1]. It is well acknowledged that the dysfunction of lung fibroblasts is partially responsible for small airway remodeling and peripheral emphysema in the progression of COPD [5, 6]. From another perspective, fibroblasts are gradually believed to be involved in the inflammatory process in the lung along with neutrophils, macrophages, T cells, and epithelial cells [7]. We assumed that pulmonary fibroblasts in patients with COPD could participate in the local inflammation by producing a higher level of IL-6 and IL-8

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call